Parison Amy 4
4 · Editas Medicine, Inc. · Filed Aug 8, 2025
Insider Transaction Report
Form 4
Parison Amy
SVP, Chief Financial Officer
Transactions
- Sale
Common Stock
2025-08-07$2.58/sh−679$1,752→ 16,827 total
Footnotes (1)
- [F1]Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on June 6, 2025. The sale does not represent a discretionary trade by the Reporting Person.